EdgarLookup

TENAX THERAPEUTICS, INC. — All Filings

925 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-KT 10-Q 10-Q/A 10KSB 10QSB 3 4 4/A 424B1 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A EFFECT FWP NT 10-K NT 10-Q NTN 10K POS AM PRE 14A PRER14A REGDEX REGDEX/A RW S-1 S-1/A S-1MEF S-2 S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-K ANNUAL REPORT 0001654954-21-003641 Mar 31, 2021 Dec 31, 2020
8-K/A AMENDED CURRENT REPORT 0001654954-21-003529 Mar 30, 2021 Jan 15, 2021
SEC STAFF LETTER 9999999997-21-000998 Mar 29, 2021
8-K CURRENT REPORT 0001654954-21-002212 Mar 2, 2021 Feb 25, 2021
SEC STAFF LETTER 9999999997-21-000611 Mar 1, 2021
SC 13G/A 0001037389-21-000148 Feb 11, 2021
SC 13G/A TENX 13GA 0001393825-21-000069 Feb 11, 2021
4 PRIMARY DOCUMENT 0001654954-21-000839 Jan 27, 2021 Jan 15, 2021
3 PRIMARY DOCUMENT 0001654954-21-000837 Jan 27, 2021 Jan 15, 2021
8-K CURRENT REPORT 0001654954-21-000585 Jan 19, 2021 Jan 15, 2021
4 PRIMARY DOCUMENT 0001654954-21-000348 Jan 12, 2021 Jan 5, 2021
4 PRIMARY DOCUMENT 0001654954-21-000347 Jan 12, 2021 Jan 5, 2021
8-K CURRENT REPORT 0001654954-20-012680 Nov 18, 2020
10-Q QUARTERLY REPORT 0001654954-20-012485 Nov 16, 2020 Sep 30, 2020
8-K CURRENT REPORT 0001654954-20-011170 Oct 15, 2020 Oct 9, 2020
424B3 424B3 0001654954-20-010699 Oct 1, 2020
EFFECT 9999999995-20-002631 Sep 30, 2020
CORRESP 0001654954-20-010605 Sep 29, 2020
S-3/A PRIMARY DOCUMENT 0001654954-20-010005 Sep 11, 2020
CORRESP 0001654954-20-010006 Sep 11, 2020
4 0000919574-20-005750 Sep 9, 2020 Sep 4, 2020
UPLOAD 0000000000-20-008381 Sep 4, 2020
4 0000919574-20-005666 Sep 3, 2020 Sep 1, 2020
4 0000919574-20-005631 Aug 31, 2020 Aug 27, 2020
4 0000919574-20-005506 Aug 26, 2020 Aug 24, 2020
4 0000919574-20-005488 Aug 21, 2020 Aug 19, 2020
S-3 REGISTRATION STATEMENT 0001654954-20-009391 Aug 20, 2020
10-Q QUARTERLY REPORT 0001654954-20-009183 Aug 14, 2020 Jun 30, 2020
SC 13G/A 0000834237-20-010111 Aug 7, 2020
D 0001654954-20-007918 Jul 22, 2020
3 0000919574-20-004648 Jul 21, 2020 Jul 20, 2020
8-K FORM 8-K 0001654954-20-007819 Jul 20, 2020
3 0000919574-20-004613 Jul 16, 2020 Jul 6, 2020
SC 13D 0000919574-20-004612 Jul 16, 2020
424B5 PROSPECTUS SUPPLEMENT 0001654954-20-007442 Jul 8, 2020
8-K CURRENT REPORT 0001654954-20-007444 Jul 8, 2020 Jul 6, 2020
8-K CURRENT REPORT 0001654954-20-006776 Jun 18, 2020
4 FORM 4 0001654954-20-006645 Jun 15, 2020 May 1, 2019
8-K CURRENT REPORT 0001654954-20-006257 Jun 2, 2020
8-K CURRENT REPORT 0001654954-20-006219 Jun 2, 2020 May 29, 2020
SC 13D/A 13D/A 0001783976-20-000009 Jun 2, 2020
4 FORM 4 0001654954-20-005765 May 19, 2020 May 18, 2020
SC 13D 13D 0001783976-20-000008 May 18, 2020
4 PRIMARY DOCUMENT 0001654954-20-005679 May 15, 2020 Mar 1, 2020
4 PRIMARY DOCUMENT 0001654954-20-005665 May 15, 2020 May 1, 2020
4 PRIMARY DOCUMENT 0001654954-20-005666 May 15, 2020 May 1, 2020
4 PRIMARY DOCUMENT 0001654954-20-005667 May 15, 2020 May 1, 2020
10-Q QUARTERLY REPORT 0001654954-20-005647 May 15, 2020 Mar 31, 2020
4 PRIMARY DOCUMENT 0001654954-20-005663 May 15, 2020 Mar 1, 2020
8-K CURRENT REPORT 0001654954-20-004979 May 6, 2020 Apr 30, 2020